Osteopore Limited (ASX:OSX)
Australia · Delayed Price · Currency is AUD 0.0070
-0.0010 (-12.50%)
At close: Mar 13, 2026
Osteopore Revenue
In the year 2025, Osteopore had annual revenue of 3.06M AUD with 10.65% growth. Osteopore had revenue of 1.50M in the half year ending December 31, 2025, with 22.78% growth.
Revenue
3.06M
Revenue Growth
+10.65%
P/S Ratio
1.29
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.06M | 294.32K | 10.65% |
| Dec 31, 2024 | 2.76M | 545.37K | 24.60% |
| Dec 31, 2023 | 2.22M | 525.02K | 31.02% |
| Dec 31, 2022 | 1.69M | 579.38K | 52.06% |
| Dec 31, 2021 | 1.11M | -391.57K | -26.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.10B |
| Sigma Healthcare | 9.55B |
| Cochlear | 2.34B |
| Pro Medicus | 240.57M |
| Freedom Care Group Holdings | 28.10M |
| Elixinol Wellness | 15.50M |
| Global Health | 8.46M |
| Acrux | 2.81M |